Several acetylcholinesterase inhibitors including tacrine, rivastigmine, and donepezil are used in the treatment of individuals with moderate Alzheimer’s disease by inhibiting the breakdown of acetylcholine21. The gene discussed is ACHE; the disease is early-onset autosomal dominant Alzheimer disease.